当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析 - 资产负债表

昭衍新药

(603127)

  

流通市值:120.55亿  总市值:143.30亿
流通股本:6.30亿   总股本:7.49亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金676,571,156.45965,203,128.591,840,124,511.872,158,195,144.93
应收票据及应收账款198,669,231.02218,002,950.36228,563,668.14209,418,805.35
其中:应收票据19,757,152.3436,835,066.3715,521,997.97,022,479.88
应收账款178,912,078.68181,167,883.99213,041,670.24202,396,325.47
预付款项66,473,403.3363,603,854.5893,367,592.0399,241,416.29
其他应收款合计8,170,222.648,488,030.6611,307,419.4913,963,016.36
存货1,528,404,534.71,478,547,177.811,631,793,427.451,632,144,111.85
合同资产104,715,217.02121,996,566.95101,229,555.78108,669,964.67
一年内到期的非流动资产940,288,560.33729,846,540.9--
其他流动资产45,397,734.1849,386,329.3545,527,967.0543,198,101.9
流动资产平衡项目0000
流动资产合计5,063,761,087.585,031,197,927.385,334,112,028.965,492,884,034.54
非流动资产:
其他权益工具投资91,000,00091,000,000159,840,000159,840,000
其他非流动金融资产631,009,195.44624,973,939.54614,027,609.91615,111,190.7
固定资产677,345,597.14696,785,630.77669,976,461.06678,398,553.13
在建工程394,629,147.57368,927,206.62323,645,798.21309,219,257.1
生产性生物资产373,378,624.23383,304,545.59393,069,851.01400,440,438.09
使用权资产44,254,815.6552,612,530.5464,522,594.9451,140,402.28
无形资产294,694,673.84298,514,374.33294,064,206.17298,683,799.02
商誉137,840,937.93138,036,805.64134,561,113.99136,853,918.31
长期待摊费用60,165,649.0263,055,662.4567,282,378.567,924,692.18
递延所得税资产33,995,873.8533,356,441.1439,181,770.5637,515,704.57
其他非流动资产1,622,583,007.271,614,387,546.451,430,900,994.671,413,261,698.76
非流动资产平衡项目0000
非流动资产合计4,360,897,521.944,364,954,683.074,191,072,779.024,168,389,654.14
资产平衡项目0000
资产总计9,424,658,609.529,396,152,610.459,525,184,807.989,661,273,688.68
流动负债:
应付票据及应付账款44,537,300.5850,222,333.8639,305,320.9164,586,862.47
应付账款44,537,300.5850,222,333.8639,305,320.9164,586,862.47
合同负债871,306,662.06827,161,128.21,064,046,398.381,128,532,303.86
应付职工薪酬63,929,189.33103,371,485.3782,520,776.7687,934,760.93
应交税费14,419,001.1123,800,985.718,611,739.5216,809,779.44
其他应付款合计68,160,052.2562,647,485.5462,202,411.21188,708,562.66
应付股利---119,976,877.6
一年内到期的非流动负债32,120,462.5739,373,610.538,697,752.5427,925,552.36
其他流动负债3,186,695.533,991,567.13,322,471.243,696,990.77
流动负债平衡项目0000
流动负债合计1,097,659,363.431,110,568,596.281,298,706,870.561,518,194,812.49
非流动负债:
租赁负债20,996,748.8321,599,642.9532,771,963.2228,958,829.55
递延收益79,606,862.9967,920,688.5569,616,218.9970,596,288.57
递延所得税负债117,189,711.21116,875,428.71133,255,156.98128,282,329.63
非流动负债平衡项目0000
非流动负债合计217,793,323.03206,395,760.21235,643,339.19227,837,447.75
负债平衡项目0000
负债合计1,315,452,686.461,316,964,356.491,534,350,209.751,746,032,260.24
所有者权益(或股东权益):
实收资本(或股本)749,477,334749,477,334749,477,334749,888,699
资本公积5,237,665,882.345,237,665,882.345,250,020,019.415,267,128,243.75
减:库存股230,898,376.4220,563,519.61211,100,000.16223,058,771.92
其他综合收益48,710,113.6249,477,052.9895,658,951.64103,543,055.25
盈余公积167,792,770.8167,792,770.8144,259,244.76144,259,244.76
未分配利润2,136,088,558.442,094,969,066.211,974,120,132.551,874,251,942.36
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计8,108,836,282.88,078,818,586.728,002,435,682.27,916,012,413.2
少数股东权益369,640.26369,667.24-11,601,083.97-770,984.76
股东权益平衡项目0000
股东权益合计8,109,205,923.068,079,188,253.967,990,834,598.237,915,241,428.44
负债和股东权益合计9,424,658,609.529,396,152,610.459,525,184,807.989,661,273,688.68
公告日期2025-04-292025-03-292024-10-312024-08-31
审计意见(境内)标准无保留意见
TOP↑